IGPA welcomes WTO and WIPO DGs

22 December 2008

The International Generic Pharmaceutical Association's annual conference in Geneva, Switzerland, has been the forum for a series of discussions about the direction of intellectual property rights and access to medicines. Among the key speakers were World Trade Organization Director General Pascal Lamy and his World Intellectual Property Organization counterpart, Francis Gurry.

Mr Lamy was welcomed by delegates, especially with his statement that "no one should make confusion between substandard, counterfeit medicines and generics," the IP Watch reported. Mr Gurry received a rather less enthusiastic response for his call of "respect for IP" from the assembled mixture of generic drugmakers and anti-patent activists.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight